{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:58:42Z","timestamp":1792403922337,"version":"4.4.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003958","name":"Stichting voor de Technische Wetenschappen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Netherlands Organisation for Scientific Research","doi-asserted-by":"publisher","award":["NWO 14654"],"award-info":[{"award-number":["NWO 14654"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.phro.2024.100605","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:21:25Z","timestamp":1719447685000},"page":"100605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Comparison of stereotactic radiotherapy and protons for uveal melanoma patients"],"prefix":"10.1016","volume":"31","author":[{"given":"Emmanuelle","family":"Fleury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Pignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Kili\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Milder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"van Rij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Naus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Yavuzyigitoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"den Toom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Zolnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kees","family":"Spruijt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"van Vulpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Trnkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mischa","family":"Hoogeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2024.100605_b0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/CMR.0000000000000199","article-title":"Robotic radiosurgery for the treatment of medium and large uveal melanoma","volume":"26","author":"Eibl-Lindner","year":"2016","journal-title":"Melanoma Res"},{"key":"10.1016\/j.phro.2024.100605_b0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13014-018-1088-9","article-title":"Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma","volume":"13","author":"Akbaba","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2024.100605_b0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(00)00164-X","article-title":"Local tumor control and morbidity after one to three fractions of stereotactic external beam irradiation for uveal melanoma","volume":"55","author":"Zehetmayer","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100605_b0020","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0161-6420(99)00081-0","article-title":"Stereotactic radiation therapy for malignant choroidal tumors: Preliminary, short-term results","volume":"107","author":"Bellmann","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.phro.2024.100605_b0025","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1016\/j.ijrobp.2011.05.012","article-title":"Stereotactic fractionated radiotherapy in the treatment of juxtapapillary choroidal melanoma: the McGill University experience","volume":"81","author":"Al-Wassia","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0030","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/bjo.2008.153429","article-title":"Stereotactic radiotherapy for treatment of juxtapapillary choroidal melanoma: 3-year follow-up","volume":"93","author":"Krema","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.phro.2024.100605_b0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijrobp.2010.04.035","article-title":"Local tumor control, visual acuity, and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007","volume":"81","author":"Dunavoelgyi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0040","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0360-3016(02)04119-6","article-title":"Impact of a micromultileaf collimator on stereotactic radiotherapy of uveal melanoma","volume":"55","author":"Georg","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0045","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.ijrobp.2006.01.005","article-title":"Optimizing LINAC-based stereotactic radiotherapy of uveal melanomas: 7 years\u2019 clinical experience","volume":"66","author":"Dieckmann","year":"2006","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.phro.2024.100605_b0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/0284186X.2020.1820572","article-title":"Hypofractionated stereotactic photon radiotherapy of choroidal melanoma: 20-year experience","volume":"60","author":"Eibenberger","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2024.100605_b0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijrobp.2011.06.1957","article-title":"Radiogenic side effects after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007","volume":"83","author":"Dunavoelgyi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0060","unstructured":"Health Council of the Netherlands. Proton radiotherapy. Horizon scanning report. The Hague: Health Council of the Netherlands 2009, publication no. 2009\/17E."},{"key":"10.1016\/j.phro.2024.100605_b0065","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ijrobp.2006.01.020","article-title":"Proton beam radiotherapy for uveal melanoma: Results of Curie Institut-Orsay Proton Therapy Center (ICPO)","volume":"65","author":"Dendale","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0070","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2005.01.016","article-title":"Proton beam radiotherapy of choroidal melanoma: The Liverpool-Clatterbridge experience","volume":"62","author":"Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0075","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archopht.120.12.1665","article-title":"Evidence-Based Estimates of Outcome in Patients Irradiated for Intraocular Melanoma","volume":"120","author":"Gragoudas","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.phro.2024.100605_b0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2013.05.051","article-title":"Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: A detailed analysis of tumor and dose-volume parameters","volume":"87","author":"Mishra","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ajo.2016.02.027","article-title":"Outcomes after Proton Beam Therapy for Large Choroidal Melanomas in 492 Patients","volume":"165","author":"Bensoussan","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.phro.2024.100605_b0090","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5114\/jcb.2021.106191","article-title":"Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis","volume":"13","author":"Karimi","year":"2021","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.phro.2024.100605_b0095","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamaophthalmol.2014.111","article-title":"Plaque radiotherapy for juxtapapillary choroidal melanoma: Treatment complications and visual outcomes in 650 consecutive cases","volume":"132","author":"Sagoo","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.phro.2024.100605_b0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejca.2016.09.009","article-title":"Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome","volume":"68","author":"Marinkovic","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.phro.2024.100605_b0105","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/bjophthalmol-2017-310688","article-title":"Ruthenium-106 brachytherapy for iris and iridociliary melanomas","volume":"102","author":"Marinkovic","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.phro.2024.100605_b0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajo.2022.12.021","article-title":"Robotic CyberKnife Radiosurgery for the Treatment of Choroidal and Ciliary Body Melanoma","volume":"250","author":"Liegl","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.phro.2024.100605_b0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.radonc.2011.06.038","article-title":"Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results","volume":"102","author":"Muller","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100605_b0120","first-page":"e94","article-title":"Meta-analysis on the utility of radiotherapy for the treatment of Ocular Melanoma","volume":"171","author":"Messineo","year":"2020","journal-title":"Clin Ter"},{"key":"10.1016\/j.phro.2024.100605_b0125","doi-asserted-by":"crossref","unstructured":"Kosydar S, Robertson JC, Woodfin M, Mayr NA, Sahgal A, Timmerman RD et al. Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma. Am J Clin Oncol; 44:32\u201342. doi: 10.1097\/COC.0000000000000775.","DOI":"10.1097\/COC.0000000000000775"},{"key":"10.1016\/j.phro.2024.100605_b0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/cancers15020333","article-title":"Ocular Complications of Radiotherapy in Uveal Melanoma","volume":"15","author":"Zemba","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.phro.2024.100605_b0135","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3390\/cancers14051194","article-title":"Non-Cancer Effects following Ionizing Irradiation Involving the Eye and Orbit","volume":"14","author":"Thariat","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.phro.2024.100605_b0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1118\/1.595258","article-title":"Planning proton therapy of the eye","volume":"10","author":"Goitein","year":"1983","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2024.100605_b0145","series-title":"AJCC Cancer Staging Manual","first-page":"805","article-title":"Uveal melanoma","author":"Kivel\u00e4","year":"2016"},{"key":"10.1016\/j.phro.2024.100605_b0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00066-018-1416-x","article-title":"ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams","volume":"195","author":"Wilke","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.phro.2024.100605_b0155","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijrobp.2003.08.029","article-title":"A modified relocatable stereotactic frame for irradiation of eye melanoma: Design and evaluation of treatment accuracy","volume":"58","author":"Muller","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0160","unstructured":"ICRU Report 78: Prescribing, Recording, and Reporting Proton-Beam Therapy. Int Comm Radiat Units Mea 2007."},{"key":"10.1016\/j.phro.2024.100605_b0165","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apradiso.2008.06.012","article-title":"Protontherapy of eye tumours in the UK: A review of treatment at Clatterbridge","volume":"67","author":"Kacperek","year":"2008","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.phro.2024.100605_b0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.21037\/cco.2016.07.06","article-title":"Proton therapy for the management of uveal melanoma and other ocular tumors","volume":"5","author":"Mishra","year":"2016","journal-title":"Chinese Clin Oncol"},{"key":"10.1016\/j.phro.2024.100605_b0175","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0360-3016(02)04200-1","article-title":"Eye retention after proton beam radiotherapy for uveal melanoma","volume":"55","author":"Egger","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5114\/wo.2014.42233","article-title":"Preliminary results of proton radiotherapy for choroidal melanoma - The Krak\u00f3w experience","volume":"18","author":"Sas-Korczynska","year":"2014","journal-title":"Wspolczesna Onkol"},{"key":"10.1016\/j.phro.2024.100605_b0185","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ajo.2015.06.017","article-title":"Local Recurrence after Primary Proton Beam Therapy in Uveal Melanoma: Risk Factors, Retreatment Approaches, and Outcome","volume":"160","author":"Seibel","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.phro.2024.100605_b0190","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/mp.14665","article-title":"Three-dimensional MRI-based treatment planning approach for non-invasive ocular proton therapy","volume":"48","author":"Fleury","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2024.100605_b0195","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.radonc.2022.04.021","article-title":"Improving organs-at-risk sparing for choroidal melanoma patients: A CT-based two-beam strategy in ocular proton therapy with a dedicated eyeline","volume":"171","author":"Fleury","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100605_b0200","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s00417-020-04780-y","article-title":"Side effects of proton beam therapy of choroidal melanoma in dependence of the dose to the optic disc and the irradiated length of the optic nerve","volume":"258","author":"Riechardt","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"39","key":"10.1016\/j.phro.2024.100605_b0205","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0360-3016(97)00557-9","article-title":"Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma","volume":"1997","author":"Daftari","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ophtha.2020.06.030","article-title":"Dose-Response and Normal Tissue Complication Probabilities after Proton Therapy for Choroidal Melanoma","volume":"128","author":"Espensen","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.phro.2024.100605_b0215","doi-asserted-by":"crossref","DOI":"10.1118\/1.4842455","article-title":"Dosimetric properties of a proton beamline dedicated to the treatment of ocular disease","volume":"41","author":"Slopsema","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2024.100605_b0220","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1002\/mp.15024","article-title":"Characterization of the HollandPTC proton therapy beamline dedicated to uveal melanoma treatment and an interinstitutional comparison","volume":"48","author":"Fleury","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2024.100605_b0225","series-title":"Ion Beam Therapy","first-page":"149","article-title":"Ocular Proton Therapy Centers","author":"Kacperek","year":"2012"},{"key":"10.1016\/j.phro.2024.100605_b0230","series-title":"Basic Clinical Radiobiology, Fifth Edit","author":"Joiner","year":"2018"},{"key":"10.1016\/j.phro.2024.100605_b0235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2020.09.033","article-title":"Radiotherapy Treatment plannINg study Guidelines (RATING): A framework for setting up and reporting on scientific treatment planning studies","volume":"153","author":"Hansen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100605_b0240","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2003.11.015","article-title":"Quantification of local rectal wall displacements by virtual rectum unfolding","volume":"70","author":"Hoogeman","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100605_b0245","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijrobp.2005.01.057","article-title":"Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study","volume":"63","author":"Weber","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0250","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00066-005-1395-6","article-title":"Proton or stereotactic photon irradiation for posterior uveal melanoma? A planning intercomparison","volume":"181","author":"H\u00f6cht","year":"2005","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.phro.2024.100605_b0255","unstructured":"Varian Medical Systems, \u201cPlanning Reference Guide for Eclipse Ocular Proton Planning Eclipse Ocular Proton Planning,\u201d no. September, 2007."},{"key":"10.1016\/j.phro.2024.100605_b0260","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41433-022-02178-0","article-title":"Proton beam radiotherapy for choroidal and ciliary body melanoma in the UK-national audit of referral patterns of 1084 cases","volume":"37","author":"Hussain","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.phro.2024.100605_b0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijrobp.2009.07.1753","article-title":"Radiation Dose-Volume Effects of Optic Nerves and Chiasm","volume":"76","author":"Mayo","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0270","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/cancers11081047","article-title":"Long-term visual outcomes for small uveal melanoma staged T1 treated by proton beam radiotherapy","volume":"11","author":"Tout\u00e9e","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.phro.2024.100605_b0275","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/eye.2015.109","article-title":"Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma","volume":"29","author":"Sikuade","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.phro.2024.100605_b0280","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijrobp.2015.12.011","article-title":"Visual Outcomes of Parapapillary Uveal Melanomas Following Proton Beam Therapy","volume":"95","author":"Thariat","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0285","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.radonc.2013.08.018","article-title":"Dose-response of critical structures in the posterior eye segment to hypofractioned stereotactic photon radiotherapy of choroidal melanoma","volume":"108","author":"Dunavoelgyi","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100605_b0290","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1002\/mp.15573","article-title":"Technical note: Impact of beam properties for uveal melanoma proton therapy\u2014An in silico planning study","volume":"49","author":"Wulff","year":"2022","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2024.100605_b0295","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/archopht.124.6.838","article-title":"Estimates of Ocular and Visual Retention Following Treatment of Extra-Large Uveal Melanomas by Proton Beam Radiotherapy","volume":"124","author":"Conway","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.phro.2024.100605_b0300","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.radonc.2021.01.030","article-title":"Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam radiotherapy in uveal melanoma","volume":"157","author":"van Beek","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100605_b0305","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00417-017-3737-3","article-title":"Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors","volume":"255","author":"Riechardt","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.phro.2024.100605_b0310","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijrobp.2010.04.073","article-title":"Neovascular glaucoma after stereotactic radiotherapy for juxtapapillary choroidal melanoma: Histopathologic and dosimetric findings","volume":"80","author":"Fernandes","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0315","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2017.02.017","article-title":"Stereotactic Radiosurgery and Fractionated Stereotactic Radiation Therapy for the Treatment of Uveal Melanoma","volume":"98","author":"Yazici","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0320","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00417-016-3429-4","article-title":"Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma","volume":"254","author":"Seibel","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.phro.2024.100605_b0325","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ijrobp.2004.07.664","article-title":"Preventing radiation retinopathy with hyperfractionation","volume":"61","author":"Monroe","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0330","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.radonc.2017.11.010","article-title":"Retina dose as a predictor for visual acuity loss in (106)Ru eye plaque brachytherapy of uveal melanomas","volume":"127","author":"Heilemann","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100605_b0335","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5114\/jcb.2013.34450","article-title":"The retina dose-area histogram: A metric for quantitatively comparing rival eye plaque treatment options","volume":"5","author":"Astrahan","year":"2013","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.phro.2024.100605_b0340","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1118\/1.3488891","article-title":"Fundus image fusion in EYEPLAN software: An evaluation of a novel technique for ocular melanoma radiation treatment planning","volume":"37","author":"Daftari","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2024.100605_b0345","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijrobp.2009.09.040","article-title":"Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific Issues","volume":"76","author":"Bentzen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100605_b0350","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canrad.2021.08.001","article-title":"Delineation of organs at risk","volume":"26","author":"No\u00ebl","year":"2022","journal-title":"Cancer\/Radiotherapie"},{"key":"10.1016\/j.phro.2024.100605_b0355","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.canrad.2010.03.008","article-title":"Dose de tol\u00e9rance \u00e0 l\u2019irradiation des tissus sains: l\u2019\u0153il","volume":"14","author":"Marchand","year":"2010","journal-title":"Cancer\/Radiotherapie"},{"key":"10.1016\/j.phro.2024.100605_b0360","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.radonc.2015.01.016","article-title":"Organs at risk in the brain and their dose-constraints in adults and in children: A radiation oncologist\u2019s guide for delineation in everyday practice","volume":"114","author":"Scoccianti","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100605_b0365","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1167\/iovs.14-15930","article-title":"Differential radiosensitivity of uveal melanoma cell lines after X-rays or carbon ions radiation","volume":"56","author":"Calipel","year":"2015","journal-title":"Inves Ophthalmol Vis Sci"},{"key":"10.1016\/j.phro.2024.100605_b0370","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.canrad.2022.03.003","article-title":"Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study","volume":"26","author":"Gerard","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.phro.2024.100605_b0375","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1120\/jacmp.v8i3.2473","article-title":"Commissioning and acceptance testing of a CyberKnife linear accelerator","volume":"8","author":"Sharma","year":"2007","journal-title":"J Appl Clin Med Phys"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631624000757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631624000757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T08:57:08Z","timestamp":1728291428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631624000757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":75,"alternative-id":["S2405631624000757"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2024.100605","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of stereotactic radiotherapy and protons for uveal melanoma patients","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2024.100605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100605"}}